You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder - 2007
Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • ascorbic acid
  • +3 more
  • Cleveland, Ohio
  • +1 more
2020-07-23
Jul 23, 2020
N
Study of Select Combinations in Adults With Myelofibrosis
Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
2021-03-02
Mar 2, 2021
N
CINC424A2X01B Rollover Protocol
Recruiting
  • Primary Myelofibrosis
  • +4 more
  • ruxolitinib tablets or oral pediatric formulation, panobinostat capsules
  • ruxolitinib tablets or oral pediatric formulation
  • Darlinghurst, New South Wales, Australia
  • +96 more
2022-03-29
Mar 29, 2022
N
Decitabine in Treating Patients With Myelofibrosis
Active, not recruiting
Has Results
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Chicago, Illinois
  • +13 more
2021-11-30
Nov 30, 2021
G
Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis - 2016
Completed
  • Myelofibrosis
  • A: Fludarabine + Busulphan
  • B: Fludarabine + Thiotepa
  • Alessandria, Italy
  • +20 more
2021-08-19
Aug 19, 2021
M
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy - 2022
Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-04
Jan 4, 2022
A
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors - 2018
Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • +20 more
  • ASN002 Dose Escalation
  • ASN002 RD
  • Tempe, Arizona
  • +13 more
2018-08-13
Aug 13, 2018
S
Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
2021-11-29
Nov 29, 2021
K
A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases - 2020
Completed
Has Results
  • Chronic Idiopathic Urticaria
  • +4 more
  • Anniston, Alabama
  • +18 more
2021-11-29
Nov 29, 2021
N
Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF - 2020
Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
2022-02-10
Feb 10, 2022
M
LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis
Active, not recruiting
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-08
Nov 8, 2021
N
Study to Assess Efficacy and Safety of NS-018 Compared to BAT in Patients With Myelofibrosis
Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
2021-11-05
Nov 5, 2021
M
Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis
Active, not recruiting
  • Myelofibrosis
  • Long-term Follow-up
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-09
Feb 9, 2022
A
Actuate 1901: 9-ING-41 in Myelofibrosis
Recruiting
  • Myelofibrosis
  • Los Angeles, California
  • +8 more
2022-03-04
Mar 4, 2022
N
Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis - 2020
Completed
  • Idiopathic Myelofibrosis
  • +2 more
  • Paris, France
  • +9 more
2021-06-22
Jun 22, 2021
D
A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT
Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Boston, Massachusetts
  • +1 more
2022-01-12
Jan 12, 2022
U
Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes - 2018
Completed
  • Polycythemia Vera
  • +2 more
    • Salt Lake City, Utah
      University of Utah
    2019-10-14
    Oct 14, 2019
    C
    A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Birmingham, Alabama
    • +151 more
    2022-04-05
    Apr 5, 2022
    M
    P1101 in Treating Patients With Myelofibrosis
    Active, not recruiting
    • Primary Myelofibrosis
    • Secondary Myelofibrosis
    • Laboratory Biomarker Analysis
    • +2 more
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    2022-01-07
    Jan 7, 2022
    K
    Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MF and CMML (HSCT 002)
    Not yet recruiting
    • Myelofibrosis
    • +2 more
    • Charlottesville, Virginia
      Danyelle Coley
    2022-01-31
    Jan 31, 2022
    C
    An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib
    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Darlinghurst, New South Wales, Australia
    • +109 more
    2022-03-15
    Mar 15, 2022
    K
    KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF
    Recruiting
    • Myelofibrosis
    • +3 more
    • Whittier, California
    • +8 more
    2021-06-11
    Jun 11, 2021
    J
    Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation
    Recruiting
    • Accelerated/Blast-phase Myeloproliferative Neoplasm
    • +2 more
    • Scottsdale, Arizona
    • +10 more
    2021-05-19
    May 19, 2021
    T
    Ropeginterferon Alfa 2b for Early Myelofibrosis
    Recruiting
    • Primary Myelofibrosis, Prefibrotic Stage
    • Myelofibrosis
    • Ropeginterferon alfa-2b
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    2021-07-25
    Jul 25, 2021
    J
    Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation
    Recruiting
    • Chronic Idiopathic Constipation
    • Shanghai, Shanghai, China
      Renji Hospital, Medical Collge of Shanghai Jiaotong University
    2021-03-17
    Mar 17, 2021